Modifiable risk factors for stroke, dementia and late-life depression: a systematic review and DALY-weighted risk factors for a composite outcomeJasper Senff, Reinier Willem Pieter Tack, Akashleena Mallick, Leidys Gutierrez-Martinez, Jonathan Duskin, Tamara N Kimball, Benjamin Y Q Tan, Zeina N Chemali, Amy Newhouse, Christina Kourkoulis, Cyprien Rivier, Guido J Falcone, Kevin N Sheth, Ronald M Lazar, Sarah IbrahimSee the full list of authors
3 April 2025
Neural (re)organisation of language and memory: implications for neuroplasticity and cognitionAlena Stasenko, Erik Kaestner, Jonathan Rodriguez, Christopher Benjamin, F Scott Winstanley, Leigh Sepeta, Jessica Horsfall, Susan Y Bookheimer, Jerry J Shih, Marc A Norman, Amanda Gooding, Carrie R McDonald
31 January 2025
Multiple metal exposures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control studyDae-Gyu Jang, John F Dou, Emily J Koubek, Samuel Teener, Lili Zhou, Kelly M Bakulski, Bhramar Mukherjee, Stuart A Batterman, Eva L Feldman, Stephen A Goutman
6 August 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, Daniel Brickman, Kaitlin B Casaletto, Stephen A Goutman, Marco Vinceti, Laynie Dratch, Jalayne J Arias, Jean Swidler, Martin R Turner, Jeremy Shefner, Henk-Jan Westeneng, Leonard H van den Berg, Ammar Al-ChalabiSee the full list of authors
21 November 2024
Poor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE studyNeil SN Graham, Grace Blissitt, Karl Zimmerman, Lydia Orton, Daniel Friedland, Emma Coady, Rhiannon Laban, Elena Veleva, Amanda J Heslegrave, Henrik Zetterberg, Susie Schofield, Nicola T Fear, Christopher J Boos, Anthony M J Bull, Alexander BennettSee the full list of authors
11 October 2024
Novel therapies in CIDPDevan Mair, Heba Madi, Filip Eftimov, Michael P Lunn, Stephen Keddie
2 October 2024
Neurocognitive and psychiatric outcomes associated with postacute COVID-19 infection without severe medical complication: a meta-analysisSarah A B Knapp, David S Austin, Stephen L Aita, Joshua E Caron, Tyler Owen, Nicholas C Borgogna, Victor A Del Bene, Robert M Roth, William P Milberg, Benjamin D Hill
24 June 2024
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profileFiona Chan, Todd A Hardy, Sameer Malik, Sudarshini Ramanathan, D Sean Riminton, Stephen W Reddel
4 July 2024
A phase I trial of accelerated intermittent theta burst rTMS for amnestic MCIStephanie Aghamoosa, James Lopez, Katrina Rbeiz, Holly H Fleischmann, Olivia Horn, Katrina Madden, Kevin A Caulfield, Michael U Antonucci, Gonzalo Revuelta, Lisa M McTeague, Andreana Benitez
6 May 2024
Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trialPhilip Sun, Shervin Badihian, Radhika Avadhani, Nathan Walborn, Anusha Yarava, Donya Alimoradi, Issam Awad, Daniel Hanley, Santosh Murthy, Wendy Ziai
26 April 2024